How Genveon Pharmaceuticals improved its
business processes with the MBIS SAP®
Genveon Pharmaceuticals released its first pharmaceutical product in 2009 in the field of the Central Nervous System and introduced many products in various fields of treatment to the service of Turkish medicine since then. Today, it has become one of the key players of the Turkish Pharmaceutical Industry extending its portfolio with value-added original and generic pharmaceutical products in specific fields of treatment such as CNS, Physical Therapy and Rehabilitation/Orthopedics, Infection, Pain, and MS.
In 2020, Genveon Pharmaceuticals incorporated the Gebze Production Facility which is considered the best in its class in Europe and Worldwide. In this facilty, products for 83 countries are being produced with certification given by healthcare authorities in 29 countries. This great investment has enabled Genveon to contribute to the Turkish Pharmaceutical Industry considerably. With this production facility and the ecosystem it has created, Genveon Pharmaceuticals aims to see the outcome of the transformation plan it has created starting from 2021 and thus aims to have a healthy and sustainable growth pursuing a road map that consists of topics such as becoming a production base for many countries and for the developed countries in particular, increasing its exports, giving value to R&D, and working to create new products.
Total modules and applications in scope:
MM, SD, PP, MES, QM, EWM, CO, FI, PM, HR, e-Transformation products (e-Invoice, e-Waybill, e-Archive, e-Ledger), Embedded Analytics
Project implementation method:
Onsite and Remote (with digital connection and communication tools)
Project completion time:
The number of companies within the scope of the project:
Genveon (financial processes of two subsidiaries Consentis and Gekem)
With the SAP® S/4HANA Project, Genveon aimed to achieve the following:
Joint system use with the Gebze factory it has incorporated
Optimizing and simplifying processes
A validated system
Having more easily accessible SAP systems
How did we succeed together with Genveon Pharmaceuticals?
In January 2020, Generica Pharmaceuticals, whose HR module was brought to life by
MBIS, stopped its other live transitions for a while as the company needed to renew the
system. With the company's system decisions, fit-gap studies started again in January 2021.
Afterward, the project started again, this time under the name Genveon Pharmaceuticals.
The project, which had started in January and had been planned to go live in 7 months, went
live on July 26.
Genveon Pharmaceutical, located in two locations, Gebze and Maslak, used the SAP system
in the Gebze location, while the Maslak location used the VERA system. The SAP S/4HANA
project was successfully brought to life with the great dedication and efficient work of the
teams in these two locations, whose working styles are very different from each other.
Without hesitation, on July 26,
Production started to work.
Waybill and invoice, goods receipts, movements within the warehouse were carried out.
Quality and maintenance procedures were carried out.
With our successful project, the following gains were achieved for Genveon Pharmaceuticals:
In terms of innovation and sustainability, a fast, reliable, and integrated information system infrastructure was established.
By ensuring data integrity, real-time, accurate reports were obtained.
Real-Time Sales-Cost Analysis was conducted.
With the successful structuring of finance and cost accounting modules, infrastructure was built, which reduced corporate costs.
Standardization was achieved by simplifying the Gebze and Maslak processes and equalising them as much as possible.
A validated system suitable for the pharmaceutical industry was devised and the documentation was completed.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
This is a pattern type cookie set by Google Analytics, where the pattern element on the name contains the unique identity number of the account or website it relates to. It appears to be a variation of the _gat cookie which is used to limit the amount of data recorded by Google on high traffic volume websites.
This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visted in an anonymous form.
16 years 5 months 1 day 11 hours
These cookies are set via embedded youtube-videos. They register anonymous statistical data on for example how many times the video is displayed and what settings are used for playback.No sensitive data is collected unless you log in to your google account, in that case your choices are linked with your account, for example if you click “like” on a video.